DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Staels B, Rubenstrunk A, Noel B. , et al.
Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Hepatology 2013;
58 (06) 1941-1952
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.